Anti-HER2 Therapy in Elderly Breast Cancer Patients

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|9|4|263-266

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.9, Iss.4, 2014-01, pp. : 263-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 639-645

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HER2 Cancer Therapy and Cardiotoxicity

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4911-4919

Bentham Science Publishers

Access to resources Recommend Favorite

The HER2 CISH pharmDx ™ Kit in the assessment of breast cancer patients for anti-HER2 treatment

By Foged Niels T   Brügmann Anja   Jørgensen Jan T  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 3, 2013-04 ,pp. : 233-242

Informa Healthcare

Access to resources Recommend Favorite

Treatment with Combinations of the Anti-HER2 Antibody Trastuzumab and Capecitabine in Advanced Metastatic Breast Cancer Patients – a Pilot Study

By  

Breast Care, Vol. 2, Iss. 4, 2007-08 ,pp. : 227-233

Karger

Access to resources Recommend Favorite

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

By Payne Kyle   Zoon Christine   Wan Wen   Marlar Khin   Keim Rebecca   Kenari Mehrab   Kazim A.   Bear Harry   Manjili Masoud  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 45-57

Springer Publishing Company

Access to resources Recommend Favorite